» Articles » PMID: 12891197

Predictors of Mortality in Younger and Older Patients with Heart Failure and Preserved or Reduced Left Ventricular Ejection Fraction

Overview
Journal Am Heart J
Date 2003 Aug 2
PMID 12891197
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Although half of elderly patients with heart failure have preserved left ventricular ejection fraction (LVEF), little is known about predictors of mortality in this group.

Methods: We reviewed the charts of 400 patients hospitalized at an academic medical center in 1999 with a principal discharge diagnosis of heart failure. Patients were divided into 4 groups on the basis of age > or =75 or <75 years and the presence of preserved or reduced LVEF. Vital status was ascertained as of October 2001.

Results: A total of 373 patients (mean age 69.1 years, 56.0% female, 47.5% nonwhite) underwent echocardiography to assess LVEF. Of these, 216 patients were <75 years of age (81 with preserved LVEF [group 1, 21.7%] and 135 with reduced LVEF [group 2, 36.2%]), and 157 were > or =75 years of age (81 with preserved LVEF [group 3, 21.7%] and 76 with reduced LVEF [group 4, 19.6%]). After a mean follow-up of 25 months, independent predictors of mortality among the 4 groups differed substantially: group 1, male sex, prescription of a calcium-channel blocker, and diuretic dose at discharge; group 2, blood urea nitrogen (BUN), lower hemoglobin level, and not being prescribed a beta-blocker at discharge; group 3, BUN; and group 4, older age, history of myocardial infarction, severity of reduced LVEF, and diuretic dose.

Conclusion: In patients with heart failure, predictors of mortality vary by age and by the presence of preserved or reduced LVEF. Traditional predictors of mortality in patients with reduced LVEF may not apply to elderly patients with preserved LVEF.

Citing Articles

Development and Validation of a Nomogram Model for Predicting the Risk of Readmission in Patients with Heart Failure with Reduced Ejection Fraction within 1 Year.

Hu Y, Wang X, Xiao S, Huan C, Wu H, Xu T Cardiovasc Ther. 2022; 2022:4143173.

PMID: 36186488 PMC: 9507773. DOI: 10.1155/2022/4143173.


Age-dependent differences in clinical phenotype and prognosis in heart failure with mid-range ejection compared with heart failure with reduced or preserved ejection fraction.

Chen X, Savarese G, Dahlstrom U, Lund L, Fu M Clin Res Cardiol. 2019; 108(12):1394-1405.

PMID: 30980205 DOI: 10.1007/s00392-019-01477-z.


Mortality in heart failure patients.

Bytyci I, Bajraktari G Anatol J Cardiol. 2015; 15(1):63-8.

PMID: 25550250 PMC: 5336901. DOI: 10.5152/akd.2014.5731.


FRAIL-HF, a study to evaluate the clinical complexity of heart failure in nondependent older patients: rationale, methods and baseline characteristics.

Vidan M, Sanchez E, Fernandez-Aviles F, Serra-Rexach J, Ortiz J, Bueno H Clin Cardiol. 2014; 37(12):725-32.

PMID: 25516357 PMC: 6647700. DOI: 10.1002/clc.22345.


Outcomes of patients with anemia and acute decompensated heart failure with preserved versus reduced ejection fraction (from the ARIC study community surveillance).

Caughey M, Avery C, Ni H, Solomon S, Matsushita K, Wruck L Am J Cardiol. 2014; 114(12):1850-4.

PMID: 25438912 PMC: 4694625. DOI: 10.1016/j.amjcard.2014.09.024.